UnitedHealth stock price slips as CEO investment report renews scrutiny
New York, February 17, 2026, 11:23 — Regular session UnitedHealth Group Incorporated dropped 0.8%, trading at $290.89 as of 11:23 a.m. ET Tuesday. The move came after a Wall Street Journal report revealed CEO Stephen Hemsley had poured tens of millions into healthcare startups via his own Cloverfields Capital. Some of these firms either compete with or count UnitedHealth as a client. According to UnitedHealth’s statement to the Journal, Hemsley “continues to comply fully with UnitedHealth Group’s conflict of interest and trading policies.” The company also told the paper Hemsley has shifted his personal healthcare investments into a trust overseen by independent trustees.
